OakChart

Nu Skin Enterprises Inc

NUSConsumer Defensive·Household & Personal Products·USA·Micro·NYSE·Nov 11 • 1:02 PM ET

3.97-0.06 (-1.36%)
2026-11-11 19:02 CET
Market cap
196.17 USD m
Revenue, TTM
1,322.05 USD m
Net income, TTM
-234.21 USD m
Free cash flow, TTM
-26.26 USD m
EPS diluted, TTM
-4.83
P/E
-
Compare

Price

NUS against its 20, 50 and 200-day averages
2050200miss
4.006.008.0010.001.1M2.2MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26NUSclose 3.9820-day 4.6850-day 4.71200-day 6.123.98

65.9% under the 52-week high of 11.67 on 16 Jan 2026. 52-week low 3.95 on 11 Nov 2026. Last 15 sessions, 30.4% high to low

Profile

NUS
52-week range, 0% of the way up
3.9911.67

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia and Pacific, Japan, Hong Kong and Taiwan, and Europe and Africa. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

IndexRUT
Employees8600
IPONov 22, 1996
Beta0.94
ATR, 14d0.26
Rel volume0.75
Short float9.44%
Insider own2.95%
Inst own73.66%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap193.49M
Enterprise Value279.27M
Income-234.21M
Sales1.32B
Book/sh11.24
Cash/sh3.42
Dividend Est.-
Dividend TTM0.24 (6.04%)
Dividend Ex-DateNov 27, 2026
Dividend Gr. 3/5Y-46.19% -30.69%
Payout7.54%
Employees8600
IPONov 22, 1996

Ratios

P/E-
Forward P/E3.43
PEG-
P/S0.15
P/B0.35
P/C1.16
P/FCF-
EV/EBITDA2.68
EV/Sales0.21
Quick Ratio1.22
Current Ratio2.04
Debt/Eq0.46
LT Debt/Eq0.42
Option/ShortYes / Yes

Earnings

EPS (ttm)-4.83
EPS next Y1.16
EPS next Q0.27
EPS this Y-35.43%
EPS next Y41.46%
EPS next 5Y-
EPS past 3/5Y15.37% -2.56%
Sales past 3/5Y-12.61% -10.47%
EPS Y/Y TTM-318.35%
Sales Y/Y TTM-15.27%
EPS Q/Q-104.48%
Sales Q/Q-14.61%
EarningsNov 05 AMC
EPS/Sales Surpr.-52.38% -5.38%

Ownership

Insider Own2.95%
Insider Trans-1.18%
Inst Own73.66%
Inst Trans1.04%
ROA-18.64%
ROE-34.77%
ROIC-30.03%
Gross Margin67.84%
Oper. Margin4.07%
Profit Margin-17.72%
SMA20-15.13%
SMA50-15.69%
SMA200-35.10%
Trades-

Technical

Shs Outstand48.70M
Shs Float47.24M
Short Float9.44%
Short Ratio8.29
Short Interest4.46M
52W High11.67 -65.94%
52W Low3.99 -0.50%
Volatility10.07% 5.25%
ATR (14)0.26
RSI (14)33.87
Beta0.94
Rel Volume0.75
Avg Volume537.39K
Volume227,660

Performance

Perf Week-20.34%
Perf Month-20.66%
Perf Quarter-18.04%
Perf Half Y-36.70%
Perf YTD-58.68%
Perf Year-58.46%
Perf 3Y-75.94%
Perf 5Y-91.16%
Perf 10Y-92.44%
Recom3.00
Target Price12.77
Prev Close4.03
Price3.97
Change %-1.36%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jan 31, 2023DowngradeJJefferiesBuy → Hold$43 → $39+881.1%
Feb 12, 2021DowngradeDDA DavidsonBuy → Neutral
Oct 02, 2020UpgradeBBofA SecuritiesUnderperform → Neutral$54 → $58+1,359.1%
Jul 02, 2020UpgradeJJefferiesHold → Buy$42 → $50+1,157.9%
Jul 02, 2020UpgradeDDA DavidsonNeutral → Buy
Mar 09, 2020DowngradeDDeutsche BankBuy → Hold$40 → $28+604.4%
Dec 05, 2019ResumedCCitigroupNeutral
Nov 06, 2019DowngradeCCitigroupBuy → Neutral
Oct 30, 2019UpgradeSStifelSell → Hold$38.50 → $45+1,032.1%
Jul 17, 2019DowngradeJJefferiesBuy → Hold$40+906.3%

Peers

Mkt cap
TickerCompanyMkt cap
USNAUsana Health Sciences Inc239.16M
HLFHerbalife Ltd1.61B
NATRNature's Sunshine Products Inc180.22M
LFVNLifevantage Corp60.87M
MTEXMannatech Inc16.13M
ELEstee Lauder Cos. Inc40.77B
ODDODDITY Tech Ltd938.87M
FTLFFitLife Brands Inc77.47M
ELFe.l.f. Beauty Inc6.99B
MEDMedifast Inc146.55M

Insider trading

6 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Winett James MDirectorJun 02 '26Sale5.627,20340,48137,448Jun 03 05:10 PM
WOODBURY EDWINA DDirectorJun 01 '26Sale5.707,20341,05762,433Jun 03 05:07 PM
Winett James MDirectorJun 02 '26Proposed Sale5.627,20340,481Jun 02 10:38 AM
WOODBURY EDWINA DDirectorJun 01 '26Proposed Sale5.707,20341,057Jun 01 12:24 PM
Nathanson LauraDirectorMay 11 '26Sale6.732,67618,00930,473May 12 04:58 PM
Nathanson LauraDirectorMay 11 '26Proposed Sale7.162,67619,160May 11 02:53 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
VDCVanguard Consumer Staples ETFAUM: 8.36B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
IWNiShares Russell 2000 Value ETFAUM: 14.10B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 206
  • Nu Skin Misses Consensus And Cuts Guidance A Third Time As Core Business Erosion Deepens (Earnings Whispers) -9.22% -9.49%
  • Nu Skin: Q3 Earnings Snapshot (Associated Press)
  • Nu Skin Enterprises Reports Third Quarter Earnings (Business Wire)
  • Nu Skin's Rebuild Faces First Test As Street Sits Above Its Lowered Profit Range (Earnings Whispers)
  • Nu Skin Enterprises to Announce Third Quarter 2026 Financial Results (Business Wire)
  • Loading…
  • Nu Skin Ranked the World's #1 Company for Beauty and Wellness Device Systems for Third Consecutive Year (Business Wire)
  • Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 2Q26 (Newsfile) -5.44%
  • Nu Skin: Q2 Earnings Snapshot (Associated Press) -6.19%
  • Nu Skin Enterprises Reports Second Quarter Results (Business Wire)
  • Nu Skin Enterprises Announces Quarterly Dividend (Business Wire)
  • Nu Skin Enterprises to Announce Second Quarter 2026 Financial Results (Business Wire)
  • Nu Skin Reaches 900 Million Meals Purchased and Donated in its Global Fight for Child Nutrition (Business Wire)
  • Stonegate Capital Partners Updates Coverage on NU Skin Enterprises Inc. (NUS) 1Q26 (Newsfile)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.1000.210-0.020311.01328.71
2026Q22026-08-100.2000.200-5.140320.11345.21
2026Q12026-05-070.1400.1500.037320.61329.71
2025Q42026-02-120.2900.3000.290370.32382.71
2025Q32025-11-060.3400.3000.340364.21374.21
2025Q22025-08-070.430-0.427386.14--
2025Q12025-05-080.230-2.136364.49--
2024Q42025-02-130.3800.215-0.726445.55436.052
2024Q32024-11-070.1700.1970.167430.15440.973
2024Q22024-08-080.2100.167-2.380439.08431.873
2024Q12024-05-080.0900.050-0.011417.31426.553
2023Q42024-02-140.370-0.0250.147488.64476.392
2023Q32023-11-01-0.7400.643-0.741498.77520.093
2023Q22023-08-010.5400.5330.536500.26509.33
2023Q12023-05-030.2300.3000.227481.46477.493
2022Q42023-02-151.1500.4431.149522.34542.323

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2016FY2.8902.9332.5502,2082,235
2017FY3.2303.2272.3602,2792,279
2018FY2.1603.5182.1582,6792,674
2019FY3.1003.1053.1032,4202,419
2020FY3.6303.4103.6272,5822,583
2021FY2.8603.9782.8642,6962,679
2022FY2.0701.7232.0742,2262,248
2023FY1.8500.0000.1721,9691,957
2024FY0.8400.675-2.9521,7321,723
2025FY1.2701.3003.1801,4851,498
2026FY-0.820--1,317
2027FY-1.160--1,474

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-06100347.5347.5347.5
2026Q4S2026-10-25100347.5347.5347.5
2026Q4S2026-08-11101347.5347.5347.5
2026Q4S2026-07-22100384384384
2026Q4S2026-05-08110384384384
2026Q4S2026-04-29100370.2370.2370.2
2026Q4S2026-02-13101370.2370.2370.2
2026Q4S2025-11-11100395395395
2026Q4S2025-11-10100395395395
2026Q4S2025-11-09100395395395
2026Q4S2025-11-08100395395395
2026Q4S2025-11-07100395395395
2026Q4S2025-11-06100392.1392.1392.1
2026Q4S2025-11-05100392.1392.1392.1

Estimate history

EPS, annual2.362.1583.1033.6272.8642.0740.172-2.9523.185-4.8281
Period201720182019202020212022202320242025TTM
EPS, quarterly0.167-0.7262.1360.4270.340.290.037-5.14-0.015
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2278.982678.992420.4162581.9342695.6692225.6591969.1311732.0841485.1591322.05
Period201720182019202020212022202320242025TTM
Sales, quarterly430.145445.552364.49386.138364.211370.32320.608320.112311.009
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual52.755.455.650.949.949.549.549.848.248.7
Period201720182019202020212022202320242025MRQ
Shares, quarterly49.749.849.449.549.148.248.648.748.7
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,322.051,485.161,732.081,969.132,225.662,695.672,581.932,420.422,678.99
Cost of Goods Sold Incl. D&A425.11453.76550.23611.85703.42751.54732.02581.42634.14
Gross Profit896.941,031.401,181.851,357.281,522.241,944.131,849.911,839.002,044.85
Selling, General and Administrative Excl. Other843.18940.521,131.081,289.221,362.901,658.261,592.351,571.571,733.32
Research and Development-10.8013.0022.6023.3027.2023.3030.1023.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income53.7590.8850.7768.06159.34285.86257.56267.43311.53
Interest Expense15.0613.9526.41-13.5011.0013.1019.2021.80
Unusual Expense80.7153.21202.3619.7945.3852.030.030.0091.47
Net Income Before Taxes-40.50196.20-175.0526.5888.97232.46256.23255.17219.67
Income Taxes193.7235.99-28.4617.98-15.8185.1964.8881.6297.78
Consolidated Net Income-234.21160.20-146.598.60104.78147.27191.35173.55121.89
Net Income From Continuing Operations-234.21160.20-146.598.60104.78147.27191.35173.55121.89
Net Income-234.21160.20-146.598.60104.78147.27191.35173.55121.89
EPS (Recurring)-3.653.93-0.100.452.703.573.633.103.29
EPS (Basic, Before Extraordinaries)-4.823.25-2.950.172.102.933.663.132.21
EPS (Diluted)-4.833.18-2.950.172.072.863.633.102.16
EBITDA104.20143.14120.58137.66231.85410.89377.72388.54394.53
Non-Operating Income (Expense)1.53172.482.94-21.69-11.499.6211.796.9521.41
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense13.2119.0411.7112.369.7716.9317.567.2321.01
Price To Earnings Ratio---16.5857.0317.8414.9913.2028.52
Price To Sales Ratio0.170.330.200.490.960.971.120.951.29
Gross Margin67.8469.4568.2368.9368.3972.1271.6575.9876.33
Operating Margin4.076.122.933.467.1610.609.9811.0511.63
Net Margin-17.7210.79-8.460.444.715.467.417.174.55
Shares Outstanding48.7048.2049.8049.5049.5049.9050.9055.6055.40
Market Capitalization196.17196.17342.51959.532,083.562,528.532,787.822,276.323,406.82

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue311.01320.11320.61370.32364.21386.14364.49445.55
Cost of Goods Sold Incl. D&A108.84101.79106.14108.34107.49120.41117.53166.41
Gross Profit202.17218.32214.46261.98256.72265.73246.96279.15
Selling, General and Administrative Excl. Other197.08198.77208.60238.74235.08234.95231.75286.35
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income5.0919.565.8723.2421.6430.7815.21-7.21
Interest Expense3.503.324.253.994.852.533.285.86
Unusual Expense0.0078.881.840.000.000.0053.2145.88
Net Income Before Taxes1.89-63.172.6018.1915.9927.41134.60-57.80
Income Taxes2.63186.620.763.70-1.086.2927.09-21.70
Consolidated Net Income-0.74-249.801.8414.4917.0821.12107.52-36.10
Net Income From Continuing Operations-0.74-249.801.8414.4917.0821.12107.52-36.10
Net Income-0.74-249.801.8414.4917.0821.12107.52-36.10
EPS (Recurring)-0.02-4.000.060.290.340.432.88-0.08
EPS (Basic, Before Extraordinaries)-0.02-5.140.040.300.350.432.16-0.73
EPS (Diluted)-0.02-5.140.040.290.340.432.14-0.73
EBITDA17.6232.2118.2136.1633.7343.8329.429.24
Non-Operating Income (Expense)0.30-0.532.82-1.06-0.80-0.84175.891.14
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.140.882.927.274.604.602.582.72
Price To Earnings Ratio-4.832.284.426.08---
Price To Sales Ratio0.170.190.250.320.390.240.220.20
Gross Margin65.0068.2066.8970.7470.4968.8267.7662.65
Operating Margin1.646.111.836.285.947.974.17-1.62
Net Margin-0.24-78.030.573.914.695.4729.50-8.10
Shares Outstanding48.7048.7048.6048.2049.1049.5049.4049.80
Market Capitalization196.17256.35350.36468.98603.38394.81360.99342.51

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments239.84197.99267.82278.51354.81423.90344.04398.26438.25
Short Term Receivables39.5450.7872.8847.3641.3063.3750.3853.2833.20
Inventories178.64190.24279.98346.18399.93314.37275.89295.82253.45
Other Current Assets84.0693.5670.9776.0762.6491.0261.7145.1748.64
Total Current Assets542.09532.58691.64748.12858.68892.66732.02792.53773.53
Net Property, Plant & Equipment451.19452.20523.07543.54581.12632.67597.93464.54464.59
Total Investments and Advances18.7539.5940.1150.0841.901.150.000.000.00
Long-Term Note Receivable---13.8717.1220.7846.8941.9943.38
Intangible Assets126.24157.90336.08273.13283.42292.51276.89286.56182.60
Deferred Tax Assets171.72174.25105.5389.7726.4835.4130.7837.3333.78
Other Assets95.34112.40110.03102.4697.7481.8984.4871.5091.99
Total Assets1,405.311,468.911,806.461,820.971,906.481,957.081,769.011,694.451,589.87
Short Term Debt Incl. Current Port. of LT Debt38.4447.9248.9054.38140.9374.9866.8569.4577.84
Accounts Payable26.1834.8843.5153.9649.9966.1738.9847.6250.34
Income Tax Payable7.35---0.0013.920.006.6713.07
Other Current Liabilities191.76213.81236.47250.90338.77387.78250.93315.91306.11
Total Current Liabilities263.73296.61328.87359.24529.69542.86356.76439.65447.37
Long Term Debt268.17430.30558.43466.15362.86425.40440.16370.34321.08
Provision for Risks Charges3.873.313.4812.3415.759.7010.099.4712.94
Deferred Tax Liabilities0.310.340.520.442.380.6310.7418.2436.72
Other Liabilities63.9886.8993.1985.5083.0284.2375.9774.8867.17
Total Liabilities600.07817.46984.50923.67993.711,062.81893.72912.58885.28
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity805.24651.46821.97897.30912.77894.27875.29781.87704.60
Total Shareholders Equity805.24651.46821.97897.30912.77894.27875.29781.87704.60
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity805.24651.46821.97897.30912.77894.27875.29781.87704.60
Total Liabilities & Stockholders Equity1,405.311,468.911,806.461,820.971,906.481,957.081,769.011,694.451,589.87
Book Value Per Share16.7113.0816.6118.1318.2917.5715.7414.1113.37
Tangible Book Value Per Share14.099.919.8212.6112.6111.8210.768.949.91
Full-Time Employees8,60011,30015,20013,40019,60026,00024,90044,90048,700
Price to Book Ratio0.360.481.172.492.773.112.604.355.02
Return on Assets11.15-8.950.475.627.6210.2710.027.428.45
Return on Equity22.00-19.901.0011.5816.3021.6320.9516.4018.91
Return on Invested Capital14.92-13.550.627.6811.5414.5013.1910.5812.62
Quick Ratio1.381.151.251.120.871.071.281.131.16
Current Ratio2.061.802.102.081.621.642.051.801.73

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-234.21160.20-146.598.60104.78147.27191.35173.55121.89
Depreciation50.4552.2669.8170.92117.02125.02120.15121.1183.00
Other Funds (Non Cash)127.49-62.58272.34138.8930.5657.0926.9813.7484.66
Funds from Operations116.02149.91140.08200.32200.74335.20326.58310.37274.62
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-100.81-69.62-28.34-81.68-92.67-193.6252.56-132.44-71.88
Cash from Operating Activities15.2180.29111.74118.64108.06141.58379.14177.93202.74
Capital Expenditures-41.46-34.28-41.58-58.49-59.06-68.61-63.82-66.07-70.37
Net Assets From Acquisitions0.000.000.00-77.280.00-18.96-14.95-8.07-38.51
Sale of Fixed Assets and Businesses0.00193.720.000.000.000.000.000.000.00
Purchase or Sale of Investments5.6310.213.621.26-8.02-1.15-0.662.730.12
Purchase of Investments-0.570.00-14.76-16.88-13.96-16.24-14.69-8.43-11.42
Sale Or Maturity of Investments6.2010.2118.3818.155.9315.0914.0411.1611.54
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources1.001.000.000.000.000.000.000.000.00
Cash from Investing Activities-34.83170.66-37.96-134.50-67.08-88.73-79.43-71.41-108.76
Cash Dividends Paid-11.62-11.83-11.93-77.62-77.02-76.27-78.39-82.19-80.58
Change in Capital Stock-16.94-21.95-2.06-8.45-70.05-80.42-138.57-0.82-58.79
Repurchase of Common Pref Stock-15.03-20.040.00-13.01-70.05-80.42-144.33-0.82-69.56
Sale of Common Pref Stock-1.91-1.91-2.064.560.000.005.760.0010.78
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.0010.78
Issuance or Reduction of Debt, Net-26.13-170.00-110.00100.0020.5038.13-28.21-69.4522.66
Change in Long Term Debt-26.13-170.00-110.00100.0020.5038.13-28.21-69.4522.66
Issuance of Long Term Debt253.6355.0015.00110.00454.92155.00115.00145.00575.15
Reduction of Long Term Debt-279.76-225.00-125.00-10.00-434.42-116.87-143.21-214.46-552.50
Net Financing Active Other Cash Flow-11.051.38-9.19-3.2027.0513.860.00-2.330.00
Other Financing Activities Uses-11.70-2.24-9.19-3.20----2.33-
Cash from Financing Activities-65.75-202.40-133.1810.73-99.50-104.70-245.17-154.79-116.71
Exchange Rate Effect-1.513.20-9.78-3.54-16.35-11.2412.51-3.01-16.75
Net Change in Cash-86.8851.75-69.17-8.67-74.87-63.0967.05-51.28-39.49
Free Cash Flow-26.2646.0170.1660.1549.0172.97315.32111.86132.37
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow-14.165.88---12.1777.2366.88
Deferred Taxes & Investment Tax Credit-0.02-55.48-18.09-51.635.82-11.911.97-14.93

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments166.64191.39200.41239.84253.00265.37
Short Term Receivables51.4148.9045.0139.5448.8959.70
Inventories191.66191.50178.60178.64178.53180.38
Other Current Assets69.7276.3698.8784.0667.7266.10
Total Current Assets479.42508.15522.89542.09548.14571.55
Net Property, Plant & Equipment446.60444.99451.96451.19455.21451.94
Total Investments and Advances0.000.000.0018.750.000.00
Intangible Assets41.1342.63122.92126.24127.82129.56
Deferred Tax Assets---171.72--
Other Assets120.92125.75279.0495.34293.23290.63
Total Assets1,088.081,121.531,376.801,405.311,424.411,443.69
Short Term Debt Incl. Current Port. of LT Debt20.0020.0020.0038.4420.0035.00
Accounts Payable26.2337.7128.8226.1828.5228.73
Income Tax Payable---7.35--
Other Current Liabilities188.95198.64208.18191.76205.91220.17
Total Current Liabilities235.19256.35257.00263.73254.44283.91
Long Term Debt232.42243.74257.61268.17271.43275.74
Provision for Risks Charges0.000.000.003.870.000.00
Deferred Tax Liabilities---0.31--
Other Liabilities72.9978.7068.1063.9898.7596.30
Total Liabilities540.60578.79582.71600.07624.61655.94
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity547.48542.74794.09805.24799.79787.75
Total Shareholders Equity547.48542.74794.09805.24799.79787.75
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity547.48542.74794.09805.24799.79787.75
Total Liabilities & Stockholders Equity1,088.081,121.531,376.801,405.311,424.411,443.69
Book Value Per Share11.2411.1416.3416.7116.2915.91
Tangible Book Value Per Share10.4010.2713.8114.0913.6913.30
Full-Time Employees---8,600--
Price to Book Ratio0.360.320.440.590.770.52
Return on Assets-18.64-16.873.9411.157.296.66
Return on Equity-34.77-32.537.0422.0014.5513.68
Return on Invested Capital-0.10-31.760.171.351.591.99
Quick Ratio1.221.241.341.381.451.38
Current Ratio2.041.982.032.062.152.01

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-0.74-249.801.8414.4917.0821.12
Depreciation12.5412.6612.3412.9112.0913.05
Other Funds (Non Cash)13.8188.5515.659.4814.5616.53
Funds from Operations23.7715.6431.5545.0642.3743.28
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-31.89-5.02-35.47-28.44-14.89-7.48
Cash from Operating Activities-8.1210.62-3.9216.6227.4835.80
Capital Expenditures-11.35-5.64-13.71-10.76-9.91-0.02
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments6.200.00-0.570.000.008.81
Purchase of Investments0.000.00-0.570.000.000.00
Sale Or Maturity of Investments6.200.000.000.000.008.81
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.001.000.000.00
Cash from Investing Activities-5.15-5.64-14.29-9.76-9.918.79
Cash Dividends Paid-2.93-2.91-2.87-2.91-2.96-2.96
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.00-5.01-11.93-5.010.00
Repurchase of Common Pref Stock0.000.00-5.01-10.02-5.010.00
Sale of Common Pref Stock0.000.000.00-1.910.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-10.54-10.49-1.86-3.25-20.649.50
Change in Long Term Debt-10.54-10.49-1.86-3.25-20.649.50
Issuance of Long Term Debt30.000.00223.630.0040.0015.00
Reduction of Long Term Debt-40.54-10.49-225.49-3.25-60.63-5.50
Net Financing Active Other Cash Flow0.000.02-10.66-0.421.732.73
Other Financing Activities Uses0.000.02-10.66-1.07-0.031.52
Cash from Financing Activities-13.47-13.38-20.40-18.50-26.889.27
Exchange Rate Effect2.00-0.62-1.37-1.52-3.066.53
Net Change in Cash-24.74-9.01-39.98-13.16-12.3760.39
Free Cash Flow-19.474.99-17.635.8617.5735.78
Price to Free Cash Flow--12.0514.0514.808.47

Revenue breakdown

Beauty2024: 681.77M 2025: 568.11M
Other Product Lines2024: 293.10M 2025: 227.98M
Wellness2024: 757.22M 2025: 689.06M
China2024: 235.24M 2025: 195.55M
Japan2024: 181.56M 2025: 174.36M
Other countries2024: 625.53M 2025: 596.81M
South Korea2024: 163.71M 2025: 130.22M
United States2024: 526.06M 2025: 388.22M
Americas2024: 322.52M 2025: 282.98M
China2024: 235.24M 2025: 195.55M
Consolidation, Policy2024: -37.97M 2025: -36.86M
Europe and Africa2024: 164.16M 2025: 150.15M
Hong Kong/Taiwan2024: 130.61M 2025: 117.38M
Japan2024: 181.56M 2025: 174.36M
Manufacturing2024: 242.23M 2025: 243.79M
Rhyz Other2024: 85.19M 2025: 17.79M
South Korea2024: 163.71M 2025: 130.22M
Southeast Asia/Pacific2024: 244.85M 2025: 209.80M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-309.44%4.5M47.2M524.33K
2026-10-159.61%4.5M47.2M538.78K
2026-09-309.77%4.6M47.2M573.15K
2026-09-1510.09%4.8M47.2M657.74K
2026-08-319.57%4.5M47.2M681.12K
2026-08-149.40%4.4M47.2M716.80K
2026-07-319.82%4.6M47.1M706.64K
2026-07-158.88%4.2M47.1M699.75K
2026-06-308.06%3.8M47.1M647.13K
2026-06-157.66%3.6M47.1M568.16K
2026-05-296.55%3.1M47.1M551.56K
2026-05-156.51%3.1M47.4M537.12K
2026-04-305.55%2.7M48.0M517.30K
2026-04-155.30%2.5M47.0M548.96K
2026-03-314.91%2.3M46.0M545.59K
2026-03-134.91%2.3M46.0M524.16K
2026-02-274.53%2.1M46.0M493.94K
2026-02-134.40%2.0M46.0M476.14K
2026-01-303.70%1.8M47.6M476.84K
2026-01-154.40%2.1M47.6M435.29K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.501.202.002.605.8211.000.000.929-0.0100.001
call5.000.000.050.051.42697.000.000.209-0.0140.002
call7.500.000.100.002.5420.000.000.081-0.0130.001
put2.500.000.050.385.60513.000.00-0.166-0.0480.002
put5.000.551.450.903.0211130.00-0.860-0.0100.001
put7.502.954.000.004.9620.000.00-0.918-0.0130.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-09-104Statement of changes in beneficial ownership of securities2026-09-09SEC
2026-08-218-KCurrent report2026-08-17SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-02144Filing for proposed sale of securities under Rule 144.SEC
2026-06-01144Filing for proposed sale of securities under Rule 144.SEC
2026-06-01S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-05-298-KCurrent report2026-05-28SEC
2026-05-21SDSpecialized Disclosure ReportSEC
2026-05-14SCHEDULE 13G/ASEC
2026-05-124Statement of changes in beneficial ownership of securities2026-05-11SEC
2026-05-11144Filing for proposed sale of securities under Rule 144.SEC
2026-05-088-KCurrent report2026-05-06SEC
2026-05-0810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-07SEC
2026-04-03ARSAnnual report to security holders. 2025-12-31SEC
2026-04-03DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-03DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-05-28SEC
2026-03-303Initial statement of beneficial ownership of securities2026-03-18SEC
2026-03-278-KCurrent report2026-03-27SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060081.54K2
2026-050018.01K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1152.86K100

Institutional holders

Manager% owned
BlackRock, Inc.8.89%
AMERICAN CENTURY COMPANIES INC4.74%
VANGUARD CAPITAL MANAGEMENT LLC4.22%
ACADIAN ASSET MANAGEMENT LLC4.00%
VANGUARD PORTFOLIO MANAGEMENT LLC3.58%
RENAISSANCE TECHNOLOGIES LLC3.31%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.3.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC2.99%
CastleKnight Management LP2.86%
DIMENSIONAL FUND ADVISORS LP2.75%

Funds

Fund% owned
Avantis U.S. Small Cap Value ETF4.75%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.02%
iShares Russell 2000 ETF2.75%
Schwab Fundamental U.S. Small Company ETF1.72%
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND1.23%
VANGUARD CONSUMER STAPLES INDEX FUND1.16%
VANGUARD EXTENDED MARKET INDEX FUND1.13%
Fidelity Small Cap Index Fund1.12%
iShares Russell 2000 Value ETF1.02%
U.S. SMALL CAP VALUE PORTFOLIO1.00%

OakChart. NUS. Cached 15 minutes.